What is Casodex?
Bicalutamide (Casodex, Cosudex, Calutide, Kalumid) is an oral non-steroidal antiandrogen used in the treatment of prostate cancer and hirsutism. It was first launched in 1995 as a combination treatment (with surgical or medical castration) for advanced prostate cancer and subsequently launched as monotherapy for the treatment of earlier stages of the disease.
Bicalutamide is marketed by AstraZeneca and several companies selling generic versions. It can be used as monotherapy or in combination with a gonadotropin-releasing hormone (GnRH) agonist or surgical castration.